The BRIDGE Study is currently enrolling patients for Bridging Anticoagulation in patients who require temporary interruption of Warfarin Therapy for an elective invasive procedure or surgery.
The study is aimed at determining the possible benefits and harmful effects of bridging anticoagulation. Sometimes during surgeries doctors switch patients from warfarin to heparin while some just stop the warfarin. The study would determine which of the strategies are best for preventing arterial thrombotic events (ATEs).
To find out if you are eligible for participating in the study, use the form.
- BRIDGE Study: Bridging Anticoagulation in Patients Who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive ProceDure or Surgery
- Dr.Manesh Patel et al. Report Rivaroxaban Alternative to Warfarin is Equally Effective in Preventing Stroke in Atrial Fibrillation Patients
- Summary of Atrial Fibrillation Clinical Trials
- Cardiac Surgery Clinical Trials
- Diabetes May Be Reversed By Adjustable Gastric Band Surgery:Dutch Meta-analysis Study Suggests